58
Views
6
CrossRef citations to date
0
Altmetric
Commentary

Ga-67 SPECT: ave atque vale! Or have we bid a premature farewell to a trusted friend?

Pages 2440-2442 | Published online: 01 Jul 2009

References

  • Fruchart, , et al. Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study. Leuk Lymphoma 2006; 47: 2547–2557
  • Hicks R J, Mac Manus M P, Seymour J F. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005; 35: 165–175
  • Edwards C L, Hayes R L. Tumor scanning with 67Ga citrate. J Nucl Med 1969; 10: 103–105
  • Adler S, Parthasarathy K L, Bakshi S P, Stutzman L. Gallium-67-citrate scanning for the localization and staging of lymphomas. J Nucl Med 1975; 16: 255–260
  • Henkin R E. Gallium-67 citrate scanning in malignant lymphoma. CRC Crit Rev Clin Radiol Nucl Med 1975; 7: 65–96
  • Levi J A, O'Connell M J, Murphy W L, Sutherland J C, Wiernik P H. Role of 67gallium citrate scanning in the management of non-Hodgkin's lymphoma. Cancer 1975; 36: 1690–1741
  • Richman S D, Levenson S M, Jones A E, Johnston G S. Radionuclide studies in Hodgkin's disease and lymphomas. Semin Nucl Med 1975; 5: 103–108
  • Andrews J T, Sullivan J R, McKay W J, Hurley T H. The value of gallium-67 scanning in upper abdominal lymphomas. Med J Aust 1976; 2: 170–172
  • Martin J J, Sephton R G. Gallium-67 scanning in the malignant lymphomas. Australas Radiol 1978; 22: 340–346
  • Sephton R G, Harris A W. Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin. J Natl Cancer Inst 1975; 54: 1263–1266
  • Sephton R G, Kraft N. 67Ga and 59Fe uptakes by cultured human lymphoblasts and lymphocytes. Cancer Res 1978; 38: 1213–1216
  • Sephton R G, Hodgson G S, De Abrew S, Harris A W. Ga-67 and Fe-59 distributions in mice. J Nucl Med 1978; 19: 930–935
  • Sephton R G, De Abrew S. Effects of desferrioxamine on 67Ga distributions in tumor-bearing mice. Proc Soc Exp Biol Med 1979; 161: 402–406
  • Sephton R, Martin J J. Modification of distribution of gallium 67 in man by administration of iron. Br J Radiol 1980; 53: 572–575
  • Sephton R, Martin J. 67Ga imaging incorporating administration of iron. Int J Nucl Med Biol 1981; 8: 341–348
  • Shipp M A, Ross K N, Tamayo P, Weng A P, Kutok J L, Aguiar R C, , et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68–74
  • Wirth A, Seymour J F, Hicks R J, Ware R, Fisher R, Prince M, , et al. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med 2002; 112: 262–268
  • Lee J K, Stanley R J, Sagel S S, Levitt R G. Accuracy of computed tomography in detecting intraabdominal and pelvic adenopathy in lymphoma. AJR Am J Roentgenol 1978; 131: 311–315
  • Shimshak R R, Korobkin M, Hoffer P B, Schor R, Hill T C, Kressel H Y. The complementary role of gallium citrate imaging and computed tomography in the evaluation of suspected abdominal infection. J Nucl Med 1978; 19: 262–269
  • Front D, Israel O, Epelbaum R, Ben Haim S, Sapir E E, Jerushalmi J, , et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990; 175: 515–519
  • Kaplan W D, Jochelson M S, Herman T S, Nadler L M, Stomper P C, Takvorian T, , et al. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990; 8: 1966–1970
  • Front D, Ben-Haim S, Israel O, Epelbaum R, Haim N, Even-Sapir E, , et al. Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology 1992; 182: 359–363
  • Front D, Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995; 25: 60–71
  • Zinzani P L, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, , et al. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 1996; 22: 131–135
  • Janicek M, Kaplan W, Neuberg D, Canellos G P, Shulman L N, Shipp M A. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol 1997; 15: 1631–1637
  • Tuli M M, Al-Shemmari S H, Ameen R M, Al-Muhanadi S, Al-Huda F A, Ballani N, , et al. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma. Clin Lymphoma 2004; 5: 56–61
  • Roach P J, Janicek M J, Kaplan W D. Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response. Clin Nucl Med 1996; 21: 689–694
  • Mansberg R, Wadhwa S S, Mansberg V. Tl-201 and Ga-67 scintigraphy in non-Hodgkin's lymphoma. Clin Nucl Med 1999; 24: 239–242
  • Kostakoglu L, Leonard J P, Kuji I, Coleman M, Vallabhajosula S, Goldsmith S J. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002; 94: 879–888

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.